No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease

Inflammation

Volumn 26, Issue 1, 2002, Pages 25-30

  Altman, Raúl ^a   Rouvier, Jorge ^a   Scazziota, Alejandra ^a   Gonzalez, Claudio ^b  

^a Centro de Trombosis de Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

C reactive protein; Cardiac prosthesis; Chlamydia pneumoniae; Coronary disease; Fibrinogen

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART VALVE PROSTHESIS; HUMAN; INFLAMMATION; ISCHEMIA; MAJOR CLINICAL STUDY; ADOLESCENT; ADULT; AGED; BACTERIAL INFECTION; BLOOD; CHILD; CHRONIC DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; INFANT; MALE; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PRESCHOOL CHILD;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; FEMALE; FIBRINOGEN; HEART VALVE PROSTHESIS; HUMANS; INFANT; INFLAMMATION; ISCHEMIA; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0036126355     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014469712395     Document Type: Article

References (36)

1. Atherosclerosis. An inflammatory diseases
2. Inflammation, atherosclerosis, and ischemic events. Exploring the hidden side of the moon
3. Roles of infectious agents in atherosclerosis and restenosis
4. Chronic infections and coronary heart disease: Is there a link?
5. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease
6. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease
7. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
8. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
9. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease
10. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study
11. Chlamydia pneumoniae and atherosclerosis
12. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease
13. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
14. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis
15. Fibrinogen: A link between chronic infection and coronary heart disease
16. Elevated plasma fibrinogen. Cause or consequence of cardiovascular disease?
17. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice
18. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
19. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
20. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease
21. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
22. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
23. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease
24. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease
25. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia (ACADEMIC) study
26. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Primary clinical results of the academic study
27. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study
28. In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae
29. Alternative hypothesis for efficacy of macrolides in acute coronary syndromes
30. Macrolide antibiotics as anti-inflammatory agents: Roxithromycin in an unexpected role
31. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin
32. Elevated C-reactive protein levels in over-weight and obese adults
33. Smoldering arteries? Low-grade inflammation and coronary heart disease
34. Direct proinflammatory effect of C-reactive protein on human endothelial cells
35. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs
36. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease